Abstract |
NAMPT inhibitors may show potential as therapeutics for oncology. Throughout our NAMPT inhibitor program, we found that exposed pyridines or related heterocyclic systems in the left-hand portion of the inhibitors are necessary pharmacophores for potent cellular NAMPT inhibition. However, when combined with a benzyl group in the center of the inhibitors, such pyridine-like moieties also led to consistent and potent inhibition of CYP2C9. In an attempt to reduce CYP2C9 inhibition, a parallel synthesis approach was used to identify central benzyl group replacements with increased Fsp3. A spirocyclic central motif was thus discovered that was combined with left-hand pyridines (or pyridine-like systems) to provide cellularly potent NAMPT inhibitors with minimal CYP2C9 inhibition. Further optimization of potency and ADME properties led to the discovery of compound 68, a highly potent NAMPT inhibitor with outstanding efficacy in a mouse tumor xenograft model and lacking measurable CYP2C9 inhibition at the concentrations tested.
|
Authors | Mark Zak, Po-Wai Yuen, Xiongcai Liu, Snahel Patel, Deepak Sampath, Jason Oeh, Bianca M Liederer, Weiru Wang, Thomas O'Brien, Yang Xiao, Nicholas Skelton, Rongbao Hua, Jasleen Sodhi, Yunli Wang, Lei Zhang, Guiling Zhao, Xiaozhang Zheng, Yen-Ching Ho, Kenneth W Bair, Peter S Dragovich |
Journal | Journal of medicinal chemistry
(J Med Chem)
Vol. 59
Issue 18
Pg. 8345-68
(09 22 2016)
ISSN: 1520-4804 [Electronic] United States |
PMID | 27541271
(Publication Type: Journal Article)
|
Chemical References |
- Antineoplastic Agents
- Cytochrome P-450 CYP2C9 Inhibitors
- Enzyme Inhibitors
- Pyridines
- Cytochrome P-450 CYP2C9
- Nicotinamide Phosphoribosyltransferase
|
Topics |
- Animals
- Antineoplastic Agents
(chemistry, pharmacology, therapeutic use)
- Cell Line, Tumor
- Cytochrome P-450 CYP2C9
(metabolism)
- Cytochrome P-450 CYP2C9 Inhibitors
(chemistry, pharmacology)
- Drug Discovery
- Enzyme Inhibitors
(chemistry, pharmacology, therapeutic use)
- Female
- Humans
- Mice
- Mice, Nude
- Models, Molecular
- Neoplasms
(drug therapy)
- Nicotinamide Phosphoribosyltransferase
(antagonists & inhibitors, metabolism)
- Pyridines
(chemistry, pharmacology, therapeutic use)
|